Pexoline PR 400 Tablet contains Pentoxifylline 400mg, a hemorheologic agent indicated for improving blood flow in patients with peripheral vascular diseases, intermittent claudication, and circulatory disorders. It helps in enhancing microcirculation and oxygen delivery to tissues.
Pentoxifylline works by increasing red blood cell flexibility, reducing blood viscosity, and improving tissue perfusion. Its oral tablet formulation allows convenient administration with consistent therapeutic effects.
For distributors and healthcare suppliers, Pexoline PR 400 Tablet is a high-demand circulatory therapy product, widely prescribed in hospitals, vascular clinics, and community healthcare centers. The prevalence of peripheral vascular conditions ensures steady year-round demand.
Adding Pentozyle 400 Tablet to your vascular and circulatory support therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, clinician trust, and targeted therapeutic use make it a valuable addition to pharmaceutical distribution portfolios.